Oldest pages

Showing below up to 50 results in range #901 to #950.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Thrombotic thrombocytopenic purpura‏‎ (10:38, 20 October 2023)
  2. Haemolytic uraemic syndrome‏‎ (10:41, 20 October 2023)
  3. Aplastic anaemia‏‎ (10:45, 20 October 2023)
  4. Acute myeloid leukaemia‏‎ (10:50, 20 October 2023)
  5. Acute promyelocytic leukaemia‏‎ (10:51, 20 October 2023)
  6. Acute lymphoblastic leukaemia‏‎ (10:57, 20 October 2023)
  7. Myeloproliferative neoplasm‏‎ (10:59, 20 October 2023)
  8. Polycythaemia vera‏‎ (11:00, 20 October 2023)
  9. Essential thrombocythaemia‏‎ (11:00, 20 October 2023)
  10. Primary myelofibrosis‏‎ (11:02, 20 October 2023)
  11. Chronic myeloid leukaemia‏‎ (11:04, 20 October 2023)
  12. Chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL)‏‎ (11:10, 20 October 2023)
  13. Lymphoma‏‎ (09:39, 23 October 2023)
  14. Follicular lymphoma‏‎ (09:45, 23 October 2023)
  15. Mantle cell lymphoma‏‎ (09:47, 23 October 2023)
  16. Diffuse large B-cell lymphoma‏‎ (09:49, 23 October 2023)
  17. Burkitt lymphoma‏‎ (09:50, 23 October 2023)
  18. Graves disease‏‎ (10:57, 25 October 2023)
  19. Acute infectious thyroiditis‏‎ (11:18, 25 October 2023)
  20. Thyrotoxic crisis‏‎ (11:19, 25 October 2023)
  21. Congenital adrenal hyperplasia‏‎ (11:44, 27 October 2023)
  22. Marginal zone lymphoma‏‎ (12:13, 27 October 2023)
  23. Small bowel neoplasm‏‎ (12:15, 27 October 2023)
  24. Zollinger-Ellison syndrome‏‎ (12:20, 27 October 2023)
  25. Helicobacter pylori gastritis‏‎ (12:23, 27 October 2023)
  26. Functional bowel disorder‏‎ (12:29, 27 October 2023)
  27. Colonic polyps‏‎ (12:42, 27 October 2023)
  28. Hepatitis A‏‎ (13:40, 27 October 2023)
  29. Hepatitis B‏‎ (13:42, 27 October 2023)
  30. Hepatitis C‏‎ (13:44, 27 October 2023)
  31. Hepatitis D‏‎ (13:45, 27 October 2023)
  32. Miscellaneous hepatitis viruses‏‎ (13:48, 27 October 2023)
  33. Metabolic associated fatty liver disease‏‎ (14:04, 27 October 2023)
  34. Echinococcus cyst‏‎ (14:10, 27 October 2023)
  35. Liver abscess‏‎ (14:13, 27 October 2023)
  36. Non-HCC liver malignancies‏‎ (14:24, 27 October 2023)
  37. Autoimmune hepatitis‏‎ (14:28, 27 October 2023)
  38. Primary biliary cholangitis‏‎ (11:25, 30 October 2023)
  39. Primary sclerosing cholangitis‏‎ (13:23, 30 October 2023)
  40. Pancreatic endocrine tumours‏‎ (11:10, 2 November 2023)
  41. Haemochromatosis‏‎ (11:14, 2 November 2023)
  42. A1. Postoperative disturbances of wound healing‏‎ (11:27, 2 November 2023)
  43. A2. What is the difference between embolism and thrombosis‏‎ (11:28, 2 November 2023)
  44. A4. Types of wounds, primary wound management.‏‎ (12:03, 2 November 2023)
  45. 32. Granuloma. Granulomatous inflammation‏‎ (18:18, 2 November 2023)
  46. A3. The operative risk‏‎ (14:27, 3 November 2023)
  47. Operative risk‏‎ (14:32, 3 November 2023)
  48. Postoperative wound infection‏‎ (14:36, 3 November 2023)
  49. Wound dehiscence‏‎ (14:36, 3 November 2023)
  50. Asepsis and antisepsis‏‎ (14:41, 3 November 2023)

View ( | ) (20 | 50 | 100 | 250 | 500)